Company
Investment-firm
Last deal
Amount
Stage
Date
all rounds
Total amount
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Contact Email
Phone number
Website URL
Similar Companies1000
Axiogenesis
Axiogenesis specializes in stem cell-based assays for drug development and in vitro models of healthy and diseased cell types.
Sector
Subsector
Keywords
Location
Amniotics
Amniotics is a biopharma company specializing in mesenchymal stem cells from amniotic fluid.
Sector
Subsector
Location
total rounds
total raised
Apeiron Biologics
Apeiron Biologics is a biotech company focused on developing novel cancer immunotherapies.
Sector
Subsector
Keywords
Location
total rounds
total raised
EpiAxis Therapeutics
EpiAxis Therapeutics is a biotechnology company developing drugs to prevent metastatic disease.
Sector
Subsector
Keywords
Location
total rounds
Financials
Funding Rounds8
Number of Funding Rounds
Money Raised
Their latest funding was raised on 26.04.2023. Their latest round Post-IPO Equity
Investments1
Osiris Therapeutics
Osiris Therapeutics develops and sells regenerative medicine products to improve patient health.
Sector
Subsector
Location
total rounds
total raised
Co-Investors
Investors3
Number of lead investors
Number of investors
Australian Government for Research & Development
The Australian Government for Research & Development supports research and development initiatives in Australia.
Sector
Subsector
count Of Investments
Novaquest Capital Management
NovaQuest Capital Management, LLC manages investments in late-stage clinical and commercialized biopharmaceutical products.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Matthew Bullard
Hercules Capital
Hercules Capital, Inc. provides senior secured venture growth loans to high-growth, innovative venture capital-backed companies.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Acquisitions1
Angioblast Systems acquired by Mesoblast
acquirer
date
type
Angioblast Systems
Angioblast Systems develops and sells therapeutic products for cardiovascular diseases.
Sector
Subsector
Keywords
Location
Exits1
Osiris Therapeutics
Osiris Therapeutics develops and sells regenerative medicine products to improve patient health.
Sector
Subsector
Location
total rounds
total raised
People
Founders2
Silviu Itescu
Dr Itescu has served on Mesoblast's Board of Directors since the Company's founding in 2004, was Executive Director from 2007, and became Chief Executive Officer and Managing Director in 2011. Prior to founding Mesoblast in 2004, he established an international reputation as a physician scientist in the fields of stem cell biology, autoimmune diseases, organ transplantation, and heart failure. Dr Itescu has been a faculty member of Columbia University in New York, and the University of Melbourne and Monash University in Australia. In 2013, Dr Itescu received the inaugural Key Innovator Award from the Vatican’s Pontifical Council for Culture for his leadership in translational science and clinical medicine in relation to adult stem cell therapy. In 2011, he was named BioSpectrum Asia Person of the Year. He has consulted for various international pharmaceutical companies, has been an adviser to biotechnology and health care investor groups, and has served on the Board of Directors of several publicly listed life sciences companies.
current job
organization founded
Silviu Itescu
Employee Profiles36
Thomas Cella
Director of national accounts and hospital accounts-cellular therapy
Activity
Recent News17
The graph reveals the ratio (%) of positive news articles in a chosen time range